Compare EZPW & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EZPW | INMD |
|---|---|---|
| Founded | 1989 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 879.2M |
| IPO Year | 1991 | 2019 |
| Metric | EZPW | INMD |
|---|---|---|
| Price | $21.67 | $14.09 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | ★ $21.75 | $16.75 |
| AVG Volume (30 Days) | ★ 699.9K | 696.1K |
| Earning Date | 01-29-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.89 | 20.42 |
| EPS | 1.42 | ★ 2.21 |
| Revenue | ★ $1,274,280,000.00 | $364,494,000.00 |
| Revenue This Year | $12.38 | N/A |
| Revenue Next Year | $9.01 | $3.33 |
| P/E Ratio | $14.98 | ★ $6.38 |
| Revenue Growth | ★ 9.70 | N/A |
| 52 Week Low | $11.60 | $13.14 |
| 52 Week High | $22.11 | $19.78 |
| Indicator | EZPW | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 62.11 | 44.17 |
| Support Level | $20.93 | $13.73 |
| Resistance Level | $21.82 | $14.59 |
| Average True Range (ATR) | 0.67 | 0.43 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 83.15 | 18.80 |
EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buys and sells second-hand goods. The operating segments of the company are U.S. Pawn, Latin America Pawn, and Other Investments. The U.S. Pawn segment includes all pawn activities in the United States. The Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales, which are mainly collateral forfeited from pawn lending operations and used merchandise purchased from the customers.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.